Idiopathic Hypersomnia—A Dynamic Simulation Model [PDF]
Aims of the study:Commonly used approach to illness assessment focuses on the patient's actual state supplemented by binary records of past events and conditions.
Marek Susta +4 more
doaj +4 more sources
The Clinical and Economic Burden of Idiopathic Hypersomnia: Results from the Real-World Idiopathic Hypersomnia Total Health Model (RHYTHM) Study [PDF]
Ragy Saad,1 Sarah C Markt,1 Prasheel Lillaney,1 Deb A Profant,1 Douglas S Fuller,2 Elizabeth M Poole,1 Trevor Alvord,3 Patricia Prince,3 Shaina Desai,3 Marisa Whalen,2 Weiyi Ni,1 Jed Black1,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Jazz ...
Saad R +11 more
doaj +2 more sources
Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE) [PDF]
Logan Douglas Schneider,1 Joanne Stevens,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden2 1Stanford University Sleep Medicine Center, Stanford University School of Medicine, Stanford, CA, USA; 2Global Medical Affairs ...
Schneider LD +6 more
doaj +2 more sources
Hyperactivity in patients with narcolepsy and idiopathic hypersomnia: an exploratory study [PDF]
Introduction Patients with either Idiopathic Hypersomnia or Narcolepsy demonstrate excessive daytime somnolence (EDS) with resultant inattention mimicking Attention Deficit Hyperactivity Disorder (ADHD).
Caroline Dodson +8 more
doaj +2 more sources
Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE) [PDF]
Joanne Stevens,1 Logan D Schneider,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden1 1Global Medical Affairs, Jazz Pharmaceuticals, Philadelphia, PA, USA; 2Stanford University Sleep Medicine Center, Stanford University ...
Stevens J +6 more
doaj +2 more sources
The Clinical and Economic Burden of Idiopathic Hypersomnia and Narcolepsy: A United States Claims-Based Analysis [PDF]
Ragy Saad,1 Sarah C Markt,1 Prasheel Lillaney,1 Deb A Profant,1 Douglas S Fuller,2 Elizabeth M Poole,1 Trevor Alvord,3 Patricia Prince,3 Shaina Desai,3 Marisa Whalen,2 Weiyi Ni,1 Jed Black1,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Jazz ...
Saad R +11 more
doaj +2 more sources
Circadian Modulation of Sleep-Wake Behavior in Patients with Narcolepsy Type 1 and Idiopathic Hypersomnia [PDF]
Franziska Ryser,1,* Ann-Sophie Windirsch,2,3,* Christian R Baumann,3,4 Olivier Lambercy,1 Roger Gassert,1 Esther Werth3,4 1Rehabilitation Engineering Laboratory, Department of Health Sciences and Technology, ETH Zurich, Zurich ...
Ryser F +5 more
doaj +2 more sources
Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate [PDF]
Logan D Schneider,1 Anne Marie Morse,2 Michael J Strunc,3 Joyce K Lee-Iannotti,4 Richard K Bogan5 1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, USA; 2Janet Weis Children’s Hospital, Geisinger ...
Schneider LD +4 more
doaj +2 more sources
Single sessions of transcranial direct current stimulation and transcranial random noise stimulation exert no effect on sleepiness in patients with narcolepsy and idiopathic hypersomnia [PDF]
BackgroundHypersomnia poses major challenges to treatment providers given the limitations of available treatment options. In this context, the application of non-invasive brain stimulation techniques such as transcranial electrical stimulation (tES) may ...
Michaela Hohenester +6 more
doaj +2 more sources
A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People with Idiopathic Hypersomnia or Narcolepsy [PDF]
Introduction Low-sodium oxybate (LXB; Xywav®) is approved to treat idiopathic hypersomnia in adults and excessive daytime sleepiness or cataplexy in individuals aged ≥ 7 years with narcolepsy.
Deborah A. Nichols +8 more
doaj +2 more sources

